BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6688931)

  • 21. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T; Hirokawa N; Oike S; Maekawa T
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circadian variations in serum levels and the renal toxicity of aminoglycosides in patients.
    Prins JM; Weverling GJ; van Ketel RJ; Speelman P
    Clin Pharmacol Ther; 1997 Jul; 62(1):106-11. PubMed ID: 9246024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraplegia after intrathecal mitozantrone.
    Lakhani AK; Zuiable AG; Pollard CM; Milne A; Treleaven J; Powles RL
    Lancet; 1986 Dec; 2(8520):1393. PubMed ID: 2878247
    [No Abstract]   [Full Text] [Related]  

  • 24. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use.
    Al-Aloul M; Miller H; Alapati S; Stockton PA; Ledson MJ; Walshaw MJ
    Pediatr Pulmonol; 2005 Jan; 39(1):15-20. PubMed ID: 15521084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disability from aminoglycoside-induced vestibular paralysis.
    Proctor LR
    Johns Hopkins Med J; 1982 Oct; 151(4):162-3. PubMed ID: 7120719
    [No Abstract]   [Full Text] [Related]  

  • 26. Extended-interval aminoglycosides in children: more guidance is needed.
    Best EJ; Palasanthiran P; Gazarian M
    Pediatrics; 2005 Mar; 115(3):827-8; author reply 828. PubMed ID: 15741401
    [No Abstract]   [Full Text] [Related]  

  • 27. Aminoglycoside ototoxicity susceptibility in cystic fibrosis.
    Mulrennan SA; Helm J; Thomas RB; Dodd M; Jones A; Webb K
    Thorax; 2009 Mar; 64(3):271-2. PubMed ID: 19252031
    [No Abstract]   [Full Text] [Related]  

  • 28. Characteristics of ototoxicity of aminoglycosides "locked" to prevent hemodialysis catheter-related infections.
    Saxena AK
    Hemodial Int; 2006 Jan; 10(1):94. PubMed ID: 16441834
    [No Abstract]   [Full Text] [Related]  

  • 29. Back to the future: using aminoglycosides again and how to dose them optimally.
    Drusano GL; Ambrose PG; Bhavnani SM; Bertino JS; Nafziger AN; Louie A
    Clin Infect Dis; 2007 Sep; 45(6):753-60. PubMed ID: 17712761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Otologic side effects during drug administration].
    Buczyłko K; Baj R; Król S; Wiśnik J
    Przegl Lek; 1982; 39(5):375-8. PubMed ID: 6750702
    [No Abstract]   [Full Text] [Related]  

  • 31. Cupular deposits and aminoglycoside administration in human temporal bones.
    Kusunoki T; Cureoglu S; Schachern PA; Oktay MF; Fukushima H; Paparella MM
    J Laryngol Otol; 2005 Feb; 119(2):87-91. PubMed ID: 15829058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Neurological deficits resulting from intrathecal administration of methylene blue.
    Gross SW
    Neuroradiology; 1974; 7(2):117. PubMed ID: 4408272
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypomagnesemia is a common complication of aminoglycoside therapy.
    Zaloga GP; Chernow B; Pock A; Wood B; Zaritsky A; Zucker A
    Surg Gynecol Obstet; 1984 Jun; 158(6):561-5. PubMed ID: 6729676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycoside toxicity and relation to dose regimen.
    Barclay ML; Begg EJ
    Adverse Drug React Toxicol Rev; 1994; 13(4):207-34. PubMed ID: 7734640
    [No Abstract]   [Full Text] [Related]  

  • 35. [Aminoglycosides in pediatrics].
    Schaad UB
    Schweiz Med Wochenschr Suppl; 1996; 76():34S-38S. PubMed ID: 8677417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aminoglycosides - a current review].
    Jonsson M; Haeger K
    Lakartidningen; 1982 Feb; 79(8):651-4. PubMed ID: 7098672
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical review of the aminoglycosides.
    Nordbring F
    Scand J Infect Dis Suppl; 1980; Suppl 23():15-9. PubMed ID: 7010545
    [No Abstract]   [Full Text] [Related]  

  • 38. Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic?
    Bayer AS; Murray BE
    Clin Infect Dis; 2009 Mar; 48(6):722-4. PubMed ID: 19207080
    [No Abstract]   [Full Text] [Related]  

  • 39. Intraspinal oxidised cellulose (Surgicel) causing delayed paraplegia after thoracotomy--a report of three cases.
    Brodbelt AR; Miles JB; Foy PM; Broome JC
    Ann R Coll Surg Engl; 2002 Mar; 84(2):97-9. PubMed ID: 11995773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of thoracolumbar tuberculosis complicated with paraplegia].
    Lin Y; Guan B; Wu Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):88-90. PubMed ID: 11263391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.